Cellca (part of the Sartorius group) is a recognized leader for cell line and upstream process development. The unique Cellca CHO Expression Platform delivers high yielding, stable CHO cell lines and robust, simple fed-batch processes for the biopharmaceutical market. Since inception, Cellca has delivered over 40 cell lines expressing various biologics, which have progressed to clinical trials including monoclonal antibodies, Fc-fusion proteins, Fab-related products, bispecific antibodies and biosimilars.
Founded in 2005 and acquired by Sartorius Stedim Biotech in 2015, Cellca has now more than 80 employees and has an international steadily growing customer basis. We are looking for dedicated employees, trainees, PhD and Master students who want grow right along with us in the dynamic pharmaceutical market.
12:15 Arrival at Cellca (Erwin-Rentschler Straße 21, Reception at Rentschler)
12:45 – 13:45 Presentation of Cellca: History, Services, Structure of the company, …
13:45 – 14:00 Break
14:00 – 15:00 Facility tour
~ 16:00 Return to Ulm
Please note our terms and conditions:
- The number of participants is limited;
- the deadline for registration is 28th of April;
- registrations after the deadline cannot be accepted;
- should you have to cancel your registration, please let us know in advance via mail so that other participants get the opportunity to take part instead!
Please sign up using the online plug-in!